tetracycline hydrochloride capsule
liberty pharmaceuticals, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog
tetracycline hydrochloride capsule
rebel distributors corp - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog
tetracycline hydrochloride capsule
blenheim pharmacal, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 500 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyog
tetracycline hydrochloride capsule
state of florida doh central pharmacy - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 500 mg - tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae , mycoplasma pneumoniae (eaton agent, and klebsiellasp .) - skin and soft tissue infections caused by streptococcus pyogenes , staphylococcus aureaus . (tetracyclines are not the drugs of choice in the treatment of any type of staphylococcal infections.) - infections caused by rickettsia including rocky mountain spotted fever, typhus group infections, q fever, rickettsialpox. - psittacosis of ornithosis caused by chlamydia psittaci . - infections caused by chlamydia trachomatis such as uncomplicated urethral, endocer
tetracycline hydrochloride powder, for solution
vedco inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 714 g in 1 kg - indications: for use in the control and treatment of the following conditions in swine, calves and poultry. swine and calves indications: control and treatment of bacterial enteritis (scours) caused by escherichia coli ; bacterial pneumonia associated with actinobacillus pleuropneumoniae , pasteurella spp. and klebsiella spp. sensitive to tetracycline hydrochloride. recommended dosage level: use soluble powder in the drinking water at a drug level of tetracycline hydrochloride per gallon to provide 10 mg/lb of body weight per day in divided doses. caution: do not use for more than 5 consecutive days. directions for use: administer for 3-5 days. chickens indications: control of chronic respiratory disease (crd) and air sac disease caused by mycoplasma gallisepticum and escherichia coli ; infectious synovitis caused by mycoplasma synoviae sensitive to tetracycline hydrochloride. recommended dosage level: crd and air sac disease: use soluble powder in the drinking water at a drug level of
achromycin v - tetracycline hcl capsule
heritage pharmaceuticals inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - tetracycline hydrochloride 250 mg - to reduce the development of drug-resistant bacteria and maintain the effectiveness of achromycin v (tetracycline hcl capsules, usp) and other antibacterial drugs, achromycin v (tetracycline hcl capsules, usp) should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. achromycin v (tetracycline hcl capsules, usp) is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: achromycin v (tetracycline hcl capsules, usp) should not be used for streptococcal disease unless the organism ha
chlortetracycline soluble powder concentrate- chlortetracycline hydrochloride powder, for solution
huvepharma, inc. - chlortetracycline hydrochloride (unii: o1gx33on8r) (chlortetracycline - unii:wck1kiq23q) - chlortetracycline hydrochloride 64 g in 0.45 kg - medicate chickens and turkeys continuously at the first clinical signs of disease and continue for 7 to 14 consecutive days. the dosage ranges permitted provide for different levels based on the severity of the infection. if improvement is not noted in 24 - 48 hours, consult a veterinarian or a diagnostic laboratory to determine diagnosis and for advice regarding the optimal level of the drug where ranges are permitted. chickens control of infectious synovitis caused by mycoplasma synoviae susceptible to chlortetracycline dose mix until dissolved. 200 - 400 mg/gallon (1 - 2 packets per 512 gallons, this is equivalent to 2-4 teaspoons of powder per 5 gallons of water), administer at the indicated rates in the total water consumed over a full, 24-hour period. administer for 7 to 14 days. chickens control of chronic respiratory disease (crd) and air-sac infections caused by mycoplasma gallisepticum and escherichia coli susceptible to chlortetracycline dose mix until dissolved. 400 - 800 mg/gallon (2 - 4 pac
ccd ctc chlortetracycline hydrochloride water soluble powder
ccd animal health pty ltd - chlortetracycline hydrochloride - oral powder, pre-mix - chlortetracycline hydrochloride antibiotic active 950.0 g/kg - antibiotic & related - pigs | poultry | boar | breeders | broiler | chickens | chicks | chooks | day old chicks | gilt | hatchlings | layers | piglet | - bacterial enteritis | bacterial infection | coryza | hexamitiasis | mycoplasmosis | pasteurella multocida | pneumonia | salmonella | staphylococcus spp. | amoxycillin sensitive bacteria | associated with viral disease | bacterial pneumonia | fowl cholera | gram negative organisms | gram positive organisms | including b-lactamase producin | infectious coryza | mycoplasma gallisepticum | post parturient bacterial infe | post-weaning bacterial enterit | primary bacterial infection | salmonellosis | staphylococcosis | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
coopers engemycin 100 oxytetracycline hydrochloride 100mg/ml injection
intervet australia pty limited - oxytetracycline hydrochloride - parenteral liquid/solution/suspension - oxytetracycline hydrochloride antibiotic active 100.0 mg/ml - antibiotic & related - calf | cat | cattle | dog | horse | lamb | pig - piglet | pigs | sheep | beef | beef calf | bitch | boar | bos indicus | bos tau - bacteria
tetracycline hydrochloride capsule
breckenridge pharmaceutical, inc. - tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - to reduce the development of drug-resistant bacteria and maintain the effectiveness of tetracycline hydrochloride and other antibacterial drugs, tetracycline hydrochloride should be used only to treat infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. tetracycline is indicated in the treatment of infections caused by susceptible strains of the designated organisms in the conditions listed below: - upper respiratory tract infections caused by streptococcus pyogenes , streptococcus pneumoniae and hemophilus influenzae . note: tetracycline should not be used for streptococcal disease unless the organism has been demonstrated to be susceptible. - lower respiratory tract infections caused by streptococcus pyogenes, strep